Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various purposes such as disease diagnosis, prognosis, prediction and assessment of treatment response. The diagnostic biomarkers have early inferences for detection of Patent Ductus Arteriosus (PDA). Predictive markers provides personalize treatment regimens and prognostic markers predict patient survival and recurrence patterns. Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction and amylase for pancreatitis.
Revenue growth in the diagnostic biomarker is expected to gain traction in the near future as they are dependent on the prevalence of diseases such as cancer and other cardiac problems. Significant growth the sector of molecular biology and advancements in various laboratory techniques is expected to support the diagnostic biomarker market over the forecast period. The advancement in the technology and rise in adoption rate of the biomarkers in diagnosis has expanded the feasibility of the use of biomarkers in diagnosis of various disorders such as genetic, cardiac, cancer and other immunological diseases. Also, for clinical investigators the biomarkers can be a dynamic and powerful tool to analyze the spectrum of neurological disease.
In 2018, the global Diagnostic Biomarker market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Diagnostic Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diagnostic Biomarker development in United States, Europe and China.
The key players covered in this study
Biocrates Life Sciences
Augurex Life Sciences
Market segment by Type, the product can be split into
Market segment by Application, split into
Cancer Research Institutes
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Diagnostic Biomarker status, future forecast, growth opportunity, key market and key players.
To present the Diagnostic Biomarker development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Diagnostic Biomarker are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.